Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes.
about
Pharmacogenomics of antimicrobial agents.Budget impact analysis of CYP2C19-guided voriconazole prophylaxis in AML.Therapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of Voriconazole.Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacotherapy.Pharmacokinetic considerations in treating invasive pediatric fungal infections.Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.PharmGKB summary: voriconazole pathway, pharmacokinetics.Invasive Aspergillus infection requiring lobectomy in a CYP2C19 rapid metabolizer with subtherapeutic voriconazole concentrations.Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections.Putting CYP2C19 genotyping to the test: utility of pharmacogenomic evaluation in a voriconazole-treated haematology cohort.High metabolic N-oxidation of voriconazole in a patient with refractory aspergillosis and CYP2C19*17/*17 genotype.Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.Value of Supportive Care Pharmacogenomics in Oncology Practice.
P2860
Q34977413-0AF928EB-20EF-4A88-831D-6C250DD273E0Q36185299-1FA0FC09-13DD-4F40-BB7A-5AE4E480ACACQ36608562-22219032-52CD-47B0-9BCE-719BF88A93C2Q38775809-E8FB8709-DBDC-4B1C-BF16-98F4C4A4CC9DQ38816614-384A5FF4-72AC-48AC-B4C7-EBAAE84AD17AQ38880522-3FEF6F8A-26C6-4F36-9E38-ECDD9CAED565Q38918175-643AA474-7BEE-4603-B8F9-2FC66C638778Q39797076-E3CDBEB6-E0F7-4DB2-A38C-CB8CB5013F5DQ40290020-028130F4-CC6F-4727-A657-179D3000323CQ41564182-3777BA69-765F-4998-9C89-ED088F11D48CQ43232273-4F48E3BF-6A46-475D-8024-C455267961B8Q47781187-7446D36C-67E8-4FA9-AFAB-E0BD27D3B480Q52603826-580E98F4-107E-4929-A602-3429D4F9584F
P2860
Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Voriconazole plasma concentrat ...... ts vary by CYP2C19 diplotypes.
@ast
Voriconazole plasma concentrat ...... ts vary by CYP2C19 diplotypes.
@en
Voriconazole plasma concentrat ...... ts vary by CYP2C19 diplotypes.
@nl
type
label
Voriconazole plasma concentrat ...... ts vary by CYP2C19 diplotypes.
@ast
Voriconazole plasma concentrat ...... ts vary by CYP2C19 diplotypes.
@en
Voriconazole plasma concentrat ...... ts vary by CYP2C19 diplotypes.
@nl
prefLabel
Voriconazole plasma concentrat ...... ts vary by CYP2C19 diplotypes.
@ast
Voriconazole plasma concentrat ...... ts vary by CYP2C19 diplotypes.
@en
Voriconazole plasma concentrat ...... ts vary by CYP2C19 diplotypes.
@nl
P2093
P2860
P356
P1433
P1476
Voriconazole plasma concentrat ...... nts vary by CYP2C19 diplotypes
@en
P2093
Calvin C Daniels
Cyrine E Haidar
Deqing Pei
J Kevin Hicks
Jeffrey R Scott
John C Panetta
Kristine R Crews
Mary V Relling
Patricia Flynn
Ulrich Broeckel
P2860
P304
P356
10.2217/PGS.14.53
P577
2014-06-01T00:00:00Z